Amrutanjan Health Care Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 556.05 as of 18 May 15:30 . The P/E Ratio of Amrutanjan Health Care Ltd changed from 27.1 on March 2021 to 0 on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe P/E Ratio of Procter & Gamble Health Ltd changed from 27.3 on March 2025 to 41.7 on June 2024 . This represents a CAGR of 8.84% over 5 years The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 1661 crore on March 2021 to ₹ 0 crore on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe Market Cap of Procter & Gamble Health Ltd changed from ₹ 8535 crore on March 2025 to ₹ 8382 crore on June 2024 . This represents a CAGR of -0.36% over 5 years The revenue of Amrutanjan Health Care Ltd for the Mar '26 is ₹ 154.5 crore as compare to the Mar '25 revenue of ₹ 140.23 crore. This represent the growth of 10.18% The revenue of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Amrutanjan Health Care Ltd for the Mar '26 is ₹ 22.67 crore as compare to the Mar '25 ebitda of ₹ 22.52 crore. This represent the growth of 0.67% The ebitda of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Amrutanjan Health Care Ltd changed from ₹ 4.62 crore to ₹ 16.19 crore over 8 quarters. This represents a CAGR of 87.20% The net profit of Procter & Gamble Health Ltd changed from ₹ 82.33 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Amrutanjan Health Care Ltd changed from 20.04 % on March 2021 to 0 % on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe Dividend Payout of Procter & Gamble Health Ltd changed from 88.52 % on March 2025 to 214.75 % on June 2024 . This represents a CAGR of 19.39% over 5 years .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Pheromones have found wide application as pesticides and are used on cotton crops.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Procter & Gamble Health Ltd?

Market cap of Amrutanjan Health Care Ltd is 1,607 Cr while Market cap of Procter & Gamble Health Ltd is 8,734 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd?

The stock performance of Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd?

As of May 18, 2026, the Amrutanjan Health Care Ltd stock price is INR ₹556.05. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5261.9.

How do dividend payouts of Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.